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Abstract
Human exposure to arsenic in drinking water is known to contribute to many different health outcomes such as cancer,
diabetes, and cardiopulmonary disease. Several epidemiological studies suggest that T cell function is also altered by
drinking water arsenic exposure. However, it is unclear how individual responses differ to various levels of exposure to
arsenic. Our laboratory has recently identified differential responses of human peripheral blood mononuclear cell (HPMBC) T
cells as measured by polyclonal T cell activation by mitogens during sodium arsenite exposure. T cells from certain healthy
individuals exposed to various concentrations (1–100 nM) of arsenite in vitro showed a dose-dependent suppression at
these extremely low concentrations (,0.1–10 ppb) of arsenite, whereas other individuals were not suppressed at low
concentrations. In a series of more than 30 normal donors, two individuals were found to be sensitive to low concentration
(10 nM equivalent ,1 ppb drinking water exposure) to sodium arsenite-induced inhibition of T cell proliferation produced
by phytohemagglutinin (PHA) and anti-CD3/anti-CD28. In an arsenite-susceptible individual, arsenite suppressed the
activation of Th1 (Tbet) cells, and decreased the percentage of cells in the double positive Th17 (RORct) and Treg (FoxP3)
population. While the majority of normal blood donors tested were not susceptible to inhibition of proliferation at the 1–
100 nM concentrations of As+3, it was found that all donors were sensitive to suppression by 100 nM monomethylarsonous
acid (MMA+3), a key metabolite of arsenite. Thus, our studies demonstrate for the first time that low ppb-equivalent
concentrations of As+3 are immunosuppressive to HPBMC T cells in some individuals, but that most donor HPBMC are
sensitive to suppression by MMA+3 at environmentally relevant exposure levels.
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Introduction
Exposure of human populations to arsenic via drinking water
and diet has been determined to be a major worldwide
environmental public health issue [1]. Despite this evidence, there
has been inadequate characterization of the effects of arsenic on
the immune system of humans. Our laboratory is interested in
examining altered immune function produced by ubiquitous
environmental agents. Previous studies have shown that arsenite
may alter immune function at environmentally relevant levels of
exposure in mouse models examined in vitro and in vivo [2,3].
There have been a few studies that have examined the effects of
arsenic on human T cell immune function in human populations
exposed through drinking water. These studies are important
because infections, cancer, and other disease may result from
immune suppression. Soto-Pena et al. [4] found that phytohem-
magglutinin (PHA)-induced T cell proliferation was suppressed in
children in Mexico ingesting .100 ppb arsenite (As+3). Biswas et
al. [5] found that humans exposed to arsenic via drinking water in
Bangladesh had suppressed T cell responses to concanavallin A, as
well as decreased T cell cytokine production.
In vitro, Gonsebatt et al. [6] found that 1–100 nM concentra-
tions of As+3 prolonged the cell cycle of PBMC. More recently,
Morzadec et al. [7,8] found that HPMC exposed to 1–2 mM As+3
were suppressed in their anti-CD3/anti-CD28 stimulated T cell
proliferation and had selective effects on Th cell subsets. Because
arsenite (As+3) is metabolized to toxic species in vivo such as
MMA+3 following the action of arsenite 3-methyltransferase
(AS3MT), it is also important to examine the effects of this
arsenite metabolite on HPBMC to better understand potential
mechanisms of immunotoxicty. These studies are significant
because the AS3MT enzyme is polymorphic and differentially
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expressed in humans affecting the overall toxicity of arsenic and its
elimination from the body [9,10].
In the present studies, it was found that low concentrations 1–
100 nM range (representing low ppb levels of exposure in human
populations) of As+3 suppressed the PHA mitogen response of
human T cells in a small percentage of donors, whereas 100 nM
MMA+3 suppressed the response in the majority of donors. It also
appeared that the PHA response was more sensitive to suppression
by MMA+3 than was the anit-CD3/anti-CD28 response, suggest-




Sodium arsenite (NaAsO2), Dulbecco’s Buffered Phosphate
Solution (PBS, without calcium or magnesium), and base medium
RPMI 1640 HEPES modified were purchased from Sigma-
Aldrich (St. Louis, MO). Tritiated thymidine ([3H]-thymidine) was
purchased from Perkin Elmer (Waltham, MA).
Donor Recruitment and HPBMC Preparation
Individuals between the ages of 18 and 50 years of age who
were in good health were recruited for this study through
University of New Mexico’s (UNM) Clinical and Translational
Sciences Center (CTSC) according to our UNM Health Sciences
Human Research Review Committee approved protocol. Written
consent was obtained from participants who were non-smokers,
not pregnant, who were not currently taking any prescribed
immunosuppressants or over-the-counter medications that might
interfere with an immune response, were consented for the study.
At the time of consent blood was drawn for a complete blood cell
differential (CBC-Diff) to determine if white blood cell populations
were within the reference range and to affirm that the participant
is no anemic. If all results for the CBC-Diff were within 10% of the
reference range, 100 ml of blood was drawn in heparinized tubes
by trained personnel at the CTSC. Human peripheral blood
mononuclear cells (HPBMC) were separated according to Davila
et al. [11]. Briefly, blood was mixed 1:1 with Dulbecco’s
Phosphate Buffer Solution (DPBS2; Sigma-Aldrich, St. Louis,
MO) at room temperature. The mixture was then layered over
20 ml Fico/Lite solution (room temperature; Atlanta Biologicals
Flowery Branch, GA). The layered blood was centrifuged for
30 min at RT with no break at 4006g. The mononuclear cell
layer, at the interface of the plasma/DPBS2 and the Fico/Lite
layers, was collected and the cells were washed twice with cold
DPBS2 and counted.
T cell proliferation assay
For mitogenesis, 16105/well human peripheral blood mono-
nuclear cells (HPBMC) were incubated with 0.1, 1, 10 or 100 nM
sodium arsenite (As+3) or monomethylarsonous acid (MMA+3) in
96-well flat bottom plates coated with anti-CD3 and soluble anti-
CD28 (Affymetrix eBioscience, San Diego, CA) or in round
bottom 96-well plates for phytohemagglutinin (PHA; Roche,
Indianapolis, IN) in a humidified incubator at 37uC with 5% CO2.
After approximately 54 hrs, cells were pulsed with 1 mCi of [3H]-
thymidine and incubated overnight. The following day cells were
harvested with a Brandell model cell harvester. [3H]-Thymidine
incorporation was assessed by liquid scintillation counting (LS
6500, Beckman Coulter).
Intracellular staining of T cell transcription factors
Blood was drawn from a healthy individual as described above.
CD4 positive cells were then isolated using EasySep Human Naı¨ve
CD4+ T Cell Enrichment Kit (StemCell, Vancouver, BC,
Canada), which is a negative selection process. Briefly, cells were
resuspended to 56107 cell/ml in DPBS2 +2% FBS+1 mM EDTA
in 5 ml polystyrene tubes, and the EasySep biotinylated anti-
CD45RO antibody was added at 50 ml per ml cells. Cells were
mixed and incubated at RT for 15 min. The EasySep human
naı¨ve CD4+ T cell enrichment cocktail was added at 50 ml/ml
cells, mixed and incubated at RT for 10 min. Next the
nanoparticles supplied in the kit were added at 100 ml/ml cells,
mixed and incubated at RT for 10 min. The tube containing the
cells was placed into the magnet and left to rest for 10 min. Cells
were poured off into a new container which was placed into the
magnet and left to rest for 10 min. Following separation, cells were
poured off into a new container, counted and brought up to
16106 cell/ml. These cells were then activated using Dynabeads
Human T-Expander anti-CD3/anti-CD28 beads (Life Technol-
ogies, Grand Island, NY) and were divided into treatments and
plated for approximately 96 hr. To activate the cells the
Dynabeads were first washed following the manufacturer’s
directions, after determining the amount of beads needed. An
aliquot of cells was removed and incubated with washed M-450
Epoxy Dynabeads and utilized as an unstimulated control. As
mentioned above the cells were incubated for approximately 96 hr
in a humidified incubator at 37uC and 5% CO2. Following
activation/treatment cells were harvested into three – 12675 mm
non-sterile, round- bottom, polystyrene tubes and stained using
antibodies (Affymetrix, eBioscience, San Diego, CA) against
GATA-3, RORct, Foxp3 and T-bet transcription factors. Isotype
controls (Affymetrix, eBioscience, San Diego, CA) with the
appropriate fluorophores were also included in this assay. Foxp3
and RORct staining was done in one tube, GATA-3 and T-bet
staining was done in another tube and the isotype control was ran
in the third tube. To stain cells, they were first washed with
DPBS2+1% FBS. One ml Foxp3/Fix/Perm (eBioscience) was
added to each tube, tubes were pulse votexed and incubated at RT
for 40 min in the dark. Two ml of Permeabilization Buffer was
added to each tube. Tubes were centrifuged at 4006g for 5 min,
the supernatant was aspirated and cells were resuspended in
100 ml of Permeabilization Buffer. Either 2% normal mouse or rat
serum was added to tubes, samples were incubated at RT for
15 min to block nonspecific staining. Antibodies were added at the
recommended amounts with, isotype controls were incubated with
isotype antibodies at matching amounts. Samples were incubated
in the dark at RT for 30 min. Two ml of Permeabilization Buffer
was added to each tube. Tubes were centrifuged as described
above, aspirated, and resuspended in 400 ml Flow Cytometry
Staining Buffer. Samples were run and analyzed using the Accuri
C6 Flow Cytometer (BD Biosciences, San Jose, CA). Quadrant
analysis was used to determine the percentage of cells positive for
each transcription factor.
Urinary Arsenic Speciation Analysis
Urinary arsenic speciation was performed on an Agilent 7700x,
using anion exchange column and an ammonium carbonate
gradient using methods adapted from Milstein et al. [12]. Briefly,
the HPLC system consisted of an Agilent 1260 HPLC with
Hamilton PRP-X100 column (10 um, 25064.1 mm) and guard
cartridge. The mobile phase was ammonium carbonate (pH 8.75)
with 2% methanol in a gradient, 10 mM for 2 min, ramp to
50 mM over 1 min, and hold for 9 minutes. The column
temperature was maintained at 30uC and samples were kept at
Suppression of Human T Cells by Monomethylarsonous Acid
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4uC in a temperature-controlled autosampler. The ICP-MS with a
Micromist nebulizer (Glass Expansion) served as the detector. The
operating parameters were as follows: RF power 1550 watts,
plasma gas flow 15 L/min, carrier flow 0.85 L/min, 0.15 L/min
makeup, and arsenic was measured at 75 m/z in He mode.
Quality assurance protocol for As speciation included the use of
certified reference materials such as NIST 2669 or INSPQ urine
samples or NIST1568b rice flour. For each batch of 30 samples, at
least three samples were spiked with a low-to-mid range standard
to monitor As recovery for each species.
Statistical analysis
T-cell proliferation assays using PHA and anti-CD3/anti-CD28
were run in replicates of 6 in each treatment group. The
intracellular staining of T-cell subsets were run in replicates of 3
per treatment. Differences between treatment groups were tested
by one-way ANOVA or t-test using SigmaPlot software version
12.5 (Systat Software, Inc., Richmond, CA). Error bars indicate
the Means 6 standard deviation (SD) of the sample set. Bio
statistical significance was set at p#0.05. Box and Whisker plots
demonstrate 10th, 25th, 75th, and 90th percentiles. Filled circles
indicate outliers; red line is the mean; black line is the median. The
urinary arsenic MMA and PHA-induced cell proliferation values
were log- transformed to normalize their distributions. We
conducted a Spearman correlation between urinary arsenic
MMA and PHA-induced cell proliferation using Statistical
Analysis Software (SAS 9.3) (SAS Institute Inc.).
Results
Because we are interested in the effects of environmentally
relevant concentrations (1–300 ppb drinking water and food
equivalent) of As+3 on human T cell function, a series of
experiments were conducted in normal HPBMC to determine
the influence of As+3 on T cell proliferation. In a series of 17
normal human donors, it was found that in vitro exposure to 1–
100 nM As+3 had little effect on T cell proliferation induced by
PHA in 15 donors (Figure 1A). Two individuals were identified
who were suppressed by extremely low concentrations (0.1 and
10 nM) of As+3 (Figure 1B). This phenotype was observed on
multiple occasions in repeat studies. One of these susceptible
individuals (BD203) was further examined in a follow-up study.
In accordance with previous studies that have attempted to
characterize the target cells associated with T cell suppression [7]
by As+3, purified naı¨ve CD4 T cells representing approximately 1–
2% of total cells from the HPBMC of a sensitive donor (BD203),
were stimulated with anti-CD3 and anti-CD28 coated beads. The
potential effects of As+3 on T cell differentiation into the various
known CD4 subsets were determined by flow cytometry analysis of
transcription factor expression. Naı¨ve CD4 T cells (98–99% of
unstimulated cells seen in % Negative Stain) were identified by
lack of expression of the transcription factors for Th1 (Tbet), Th2
(GATA3), Th17 (RORct), and Treg (FoxP3). As shown in
Table 1, anti-CD3/anti-CD28 was found to activate all but 7.5–
8.9% of these cells to express some combination of these
transcription factors. It is notable that As+3 produced a concen-
tration-dependent increase in the number of Negative Staining
cells with 14.7% negative staining at 1 nM As+3 and 20.6%
negative staining in the 10 nM treatment. The results provide an
independent measure of the effects of As+3 on T cell activation in
this sensitive donor.
The primary effect of As+3 was found to be inhibition of the
differentiation of Th1 cells defined by Tbet, which declined from
82% after stimulation with anti-CD3/anti-CD28 to 74% in the
10 nM As+3 treatment group. There were very few Th2 GATA3
positive cells detected and therefore it is unclear if As+3 effects Th2
cell differentiation without further manipulation of cultures. The
Th17 population (defined by RORct) overlapped with the Treg
(FoxP3 expressing) fraction and could only be assessed in this
double-positive (DP) population. There was a small decrease from
36.1% (control) in the RORct/FoxP3 DP population to 30.3% in
the 10 nM As+3 treatment group. These results appear to be
consistent with the previous studies of Morzadec et al. [8] where
they found that the Th17 cells were the targets at higher
concentrations (1–2 mM) of As+3.
The observation that extremely low and likely environmentally
relevant concentrations of As+3 suppress T cell proliferation and
activation of Th1 cells in susceptible individuals suggested that it
might be important to measure arsenic exposures in our normal
donors. Detectable levels of arsenic and its various inorganic (As+3
and As+5) and organic (MMA, DMA) forms were found in the
urine of all donors collected as a first void on the day of the blood
draw for HPBMC assessment (Table 2). In examining that
mitogenesis data (Figure 1), high variability in the amount of T
cell proliferation in control (no As+3 treatment) cultures among
Figure 1. Evaluation of As+3 inhibition of HPBMC proliferation. In panel A, the typical response of 15 donors is shown where there is no
inhibition of PHA-induced T cell proliferation. In panel B, 2 donors are shown that were extremely sensitive to low dose (0.1–1 nM) inhibition of the
PHA response. Data shown are the Mean 6 SD with *p,.05.
doi:10.1371/journal.pone.0109192.g001
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donors was noted. Urinary arsenic metabolites expressed on a mg/
g creatinine basis. A correlation was performed for total arsenic
(inorganic + organic), inorganic arsenic (As+3 and As+5), and
organic arsenic (MMA+5, which also contains the MMA+3
fraction, and DMA+5, which also contains the DMA+3 fraction)
in the urine for donors in Figure 1. We observed a weak inverse
association between urinary MMA and the PHA-induced cell
proliferation (r = –0.24, p = 0.2) in these donors (Figure 2).
Our original assessment of T cell proliferation induced by PHA
was chosen because there are several epidemiologic studies
published in the literature that indicate that PHA induced T cell
proliferation is suppressed in individuals ingesting arsenic in
drinking water [4,5]. The stimulation of T cells via PHA is known
to require monocytes [13], which have also been shown to be
affected by As+3 at high concentrations [8,14]. Therefore, it was of
interest to compare the results for PHA stimulation with anti-
CD3/anti-CD28 activation, which is monocyte-independent
signal for T cells [13,15]. The effects of As+3 on PHA and anti-
CD3/anti-CD28 activation in 17 different individuals were
compared (Figure 3). Although the magnitude of T cell prolifer-
ation (as evidenced by higher CPM 3H-thymidine) was increased
in the anti-CD3/anti-CD28 stimulated cultures, there was no
inhibition of As+3 at environmental levels (1–100 nM) in either the
PHA or the anti-CD3/anti-CD28 treatment groups. Thus, As+3 at
these low exposure levels is not suppressive to T cell proliferation
in most individuals.
Table 1. Arsenite Suppresses Anti-CD3/Anti-CD28 Naı¨ve HPBMC T cell Differentiation.
Non-stimulated Anti-CD3/Anti-CD28 Anti-CD3/Anti-CD28+1 nM As+3 Anti-CD3/Anti-CD28+10 nM As+3
% Tbet (Th1) 1.4460.34 8261.5 7962.4 7464.4*
% Gata3 (Th2) 0.060.0 0.0360.02 0.260.05* 0.260.06*
% Tbet+Gata3 (DP) 0.060.0 1.460.3 1.060.2 0.960.07*
% Neg Stain 98.160.3 8.961.3 14.762.3 20.664.3*
% RORct (Th17) 0.460.4 54.962.0 58.360.6* 57.861.8
% FoxP3 (Treg) 0.0460.03 1.060.5 1.660.4 2.261.3
% RORct+FoxP3 (DP) 0.0160.02 36.160.6 32.560.5* 30.362.4*
% Neg Stain 99.560.4 7.561.0 7.460.4 9.362.9
Note: DP = double positive; Values shown are the Mean 6 SD with *indicating statistical significance at p,.05.
doi:10.1371/journal.pone.0109192.t001
Figure 2. Correlation analysis of MMA in urine with PHA-induced T cell stimulation (3H-Thymidine counts per minute (CPM). There is
an indication of a weak correlation between urinary MMA (combined MMA+3 and MMA+5) amounts and CPM in the 13 donors analyzed. Values are
log transformed. R =20.46, p = 0.24.
doi:10.1371/journal.pone.0109192.g002
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We have shown previously that MMA+3 is much more toxic
than As+3 to murine bone marrow cells following in vitro
exposures [3]. MMA+3 is formed, most notably in the liver and
kidney, following in vivo ingestion of arsenic in drinking water and
food. While HPBMC have extremely limited, if any, capacity to
metabolize As+3 to organic forms in vitro, due to their poor
expression of arsenite-3-methyl-transferase (AS3MT). A weak
relationship between MMA and PHA-induced proliferation was
observed (Figure 2). Therefore, the direct effects of MMA+3 on
HPBMC T cell proliferation induced by PHA and anti-CD3/anti-
CD28 were examined. MMA+3 and As+3 were compared at
environmentally relevant exposure levels in 8 individuals. In
agreement with earlier results, it was found that while As+3 at 1–
100 nM concentrations did not suppress either PHA (Figure 4A)
or anti-CD3/anti-CD28 (Figure 4C) induced T cell proliferation.
However, MMA+3 caused a statistically significant suppression of
T cell proliferation in the PHA-stimulated cultures at a
concentration of 100 nM (Figure 4B).
Discussion
Previous studies have shown that exposure of mice to 72 ppb
arsenite for 30 days in drinking water suppresses a T-dependent
antibody response in murine spleen cells [3]. This level of exposure
was also found to be associated with an increased mortality in mice
exposed to influenza virus [16]. Thus, the immune system appears
to be a very sensitive target for arsenic exposures that may be
associated with decreased host resistance to infectious agents.
Epidemiologic studies have shown that exposure of humans to
arsenic (As+3 and As+5) in drinking water may lead to suppression
of T cell proliferation [4,5]. However, there have been few studies
that have examined the mechanisms responsible for immune
suppression at environmentally relevant levels of exposures in
human T cells. Numerous in vitro studies have been conducted on
HPBMC, but most of these studies have examined extremely high
concentrations of As+3 that may not be environmentally relevant.
As+3 is known to produce oxidative stress at high concentrations
(mM range) these concentrations of As+3 may actually stimulate
proliferation and activation of many cells [17,18], including T cells
[19]. We focused on lower and more environmentally relevant
concentrations of As+3 that would be expected from ingestion of
contaminated foods and drinking water.
Because the immune system is mostly exposed to arsenic via the
blood, when performing in vitro studies it is important to consider
the actual blood levels of exposure to inorganic and organic forms
of arsenic following ingestion of contaminated drinking water and
food. Hall et al. [20] found that chronic ingestion of,50 ppb total
arsenic in drinking water resulted in blood concentrations of 5–10
ppb arsenic (all forms). In this group, ,50–200 mg total urinary
arsenic/g creatinine was reported. A 10 ppb blood level of As+3
would equate to an in vitro concentration of 133 nM. The levels
of exposure to arsenic reported in healthy donors in the present
studies (Table 2) ranged from ,4–20 mg total urinary arsenic/g
creatinine, suggesting that ambient exposures in our studies would
be estimated to be approximately 10% of that reported by Hall
[20]. Therefore, the 10–100 nM exposure range used in the
present studies for As+3 and other arsenic forms is considered to be
environmentally relevant.
We found that the level of PHA-induced T cell proliferation in
normal healthy donors was not associated with the total arsenic
levels found in the urine obtained at the time of blood donation.
The HPBMC from the majority of blood donors were not
responsive to exposure to 1–100 nM As+3 in vitro. We did find
that a small percentage (estimated at 5%) of people who were very
sensitive to T cell inhibition by low As+3 (0.1–1 nM) exposures, an
observation that was repeated on multiple occasions with blood
draws over a period of more than a year. Thus, this appears to be
a stable phenotype in these donors. While there were inadequate
numbers of these susceptible donors, to fully investigate the genetic
or other factors that determine their phenotype, it was possible to
further define the sensitivity as it pertained to the activation of
naı¨ve CD4 T cells. It was determined that Th1 cells were very
susceptible to low dose As+3 exposure, and perhaps the mixed
lineage of Th17 and Treg cell precursors was also susceptible.
Most lymphoid cells lack the capacity to methylate arsenic due
to the low expression of the arsenite-3-methyl-transferase
(AS3MT) [10,21,22]. Therefore, it is important to understand
the effects of organic (methylated) metabolites of arsenic formed in
the liver and kidney because they contribute to blood levels found
in humans. This was the rationale for examining the effects of
MMA+3 on HPBMC in the present studies. We have shown that
MMA+3 is more potent than As+3 in inhibiting mouse bone
marrow and spleen cell function [3]. Therefore, we examined the
effects of MMA+3 on T cell proliferation induced by PHA and
anti-CD3/anti-CD28. Results showed that 100 nM MMA+3
inhibited T cell proliferation and that the PHA response may be
more sensitive than the anti-CD3/anti-CD28 response. This is an
intriguing finding as the PHA response requires the presence of
macrophages [13,15] which may also be sensitive to arsenic.
Figure 3. Proliferation response of PHA and anti-CD3/anti-CD28 stimulated PBMC treated with As+3. Comparison of PHA stimulated (A)
and anti-CD3/anti-CD28 stimulated (B) T cell proliferation (3H-thymidine) for potential As+3 inhibition in 17 donors. Data shown are the Mean (red line)
and Median (black line) 6 SD with *p,.05.
doi:10.1371/journal.pone.0109192.g003
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Thus, in summary, we found that that an understanding of
arsenic metabolism and the formation of MMA+3 in vivo may be
important for examining mechanisms of arsenic immunotoxicity.
We also propose that the AS3MT status of individuals may play an
important role in determining immunosuppression produced by
environmental exposures to arsenic in human populations.
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